# Violet Therapeutics, Inc. — Form D

Violet Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-05. The offering totals $11.5M, of which $7.4M was reported sold. Industry: Other.

## Offering

- Filed: 2023-05-05
- Form: D
- Accession: 0001974912-23-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $11.5M
- Amount sold: $7.4M
- Remaining: $4.0M
- Investors: 4
- Date of first sale: 2023-04-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-480940

## Issuer

- Name: Violet Therapeutics, Inc.
- CIK: 0001974912
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: ONE MAIN STREET, CAMBRIDGE, MA, 02142
- Phone: 508-344-2319

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Jonathan Behr | Director | London, X0 |
| Meredith Fisher | Director | Half Moon Bay, CA |
| Atsushi Usami | Director | Boston, MA |
| William E Yelle | Director | Cambridge, MA |
| Meredith Fisher | Executive Officer | Half Moon Bay, CA |
| William E Yelle | Executive Officer | Cambridge, MA |

## More

- [CIK 1974912 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1974912&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001974912-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.